Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
Although contraceptive efficacy is the major reason for using oral contraceptives (OCs), other physiologic changes occur with them that can be beneficial to patients. The new, low-dose OCs are of particular interest in this regard.
D000152:Acne Vulgaris / Q000188:drug therapy; D000568:Amenorrhea / Q000139:chemically induced; D055598:Chemical Phenomena; D002621:Chemistry; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003863:Depression / Q000139:chemically induced; D004717:Endometrium / Q000187:drug effects; D045166:Estradiol Congeners / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006065:Gonadotropins, Pituitary / Q000378:metabolism; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D008597:Menstrual Cycle / Q000187:drug effects; D010053:Ovary / Q000187:drug effects; D010906:Pituitary Hormone-Releasing Hormones / Q000378:metabolism; D045167:Progesterone Congeners / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D003276:Contraceptives, Oral; D045166:Estradiol Congeners; D006065:Gonadotropins, Pituitary; D010906:Pituitary Hormone-Releasing Hormones; D045167:Progesterone Congeners